CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EUROPA aims to establish a facility for producing artificial radioisotopes using laser-plasma acceleration. This innovative approach seeks to enhance the availability of radiopharmaceuticals for cancer diagnosis and treatment, addressing the growing demand in nuclear medicine.
EUROPA envisions an innovative Artificial Radioisotope (ARI) production facility based on laser-plasma acceleration (LPA), leveraging its versatility to produce innovative radiopharmaceuticals for diagnosing and treating a wide range of cancers.
For the first time, EUROPA will demonstrate that LPA can produce ARIs with sufficient activity (in Bq) and quality for medical research.
This enables compact, easy-to-deploy ARI production units suitable for deployment in hospitals, offering a wide range…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, PESSAC
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
France, Bordeaux
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
